Deficiency in any of these cofactors may impair the glutathione redox cycle and reduce thyroid antioxidant defence
GLP-1 drugs show promise for weight management Across the reviews, tirzepatide, semaglutide, and liraglutide each led to significant weight loss compared to placebo after one to two years, with these effects likely to be sustained while treatment continues
However, it was found to selectively induce apoptosis in human lymphoma cells, Daudi, Raji and Jurkat cells, by depleting the intracellular glutathione level rather than increase it
On the other hand, participants who had diagnoses of arthritis, diabetes or heart disease had significantly lower glutathione levels than those who were disease-free
Obesity Treatments and Weight Changes in Clinical Practice After Discontinuation of Semaglutide or Tirzepatide What patients do after stopping a GLP-1 medication and how their weight changes afterward turns out to be more varied than controlled trials have suggested
Because of the safety concerns and lack of approval, it should be approached with caution and medical guidance
